Weller, M., Sahm, F., & Deimling, A. v. (2017). Durable control of metastatic AKT1-mutant WHO grade 1 meningothelial meningioma by the AKT inhibitor, AZD5363. Journal of the National Cancer Institute, 109(3), . https://doi.org/10.1093/jnci/djw320
Chicago-Zitierstil (17. Ausg.)Weller, Michael, Felix Sahm, und Andreas von Deimling. "Durable Control of Metastatic AKT1-mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363." Journal of the National Cancer Institute 109, no. 3 (2017). https://doi.org/10.1093/jnci/djw320.
MLA-Zitierstil (9. Ausg.)Weller, Michael, et al. "Durable Control of Metastatic AKT1-mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363." Journal of the National Cancer Institute, vol. 109, no. 3, 2017, https://doi.org/10.1093/jnci/djw320.